Brandon, Florida 33511

  • Pterygium of Both Eyes

Purpose:

DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation Compared to Standard of Care Topical Cortico-steroid Treatment in Patients who Undergo Bilateral Pterygium Surgery


Study summary:

In patients who undergo bilateral pterygium surgery, eyes will be randomized to receive either DEXTENZA at baseline, Month 1 and Month 2 or prednisolone x 3 months. Both eyes will receive antibiotic drops four times per day for two weeks and Maxitrol ointment at bedtime for two weeks following surgery.


Criteria:

Inclusion Criteria: patients with bilateral pterygium - Exclusion Criteria: none -


NCT ID:

NCT04351737


Primary Contact:

Michelle Fleshner, AA
Phone: 8136842211 ext. 125
Email: mfleshner@brandoneyeassociates.com


Backup Contact:

Email: haroonmd@yahoo.com
Haroon Ilyas, MD
Phone: 8136842211


Location Contact:

Brandon, Florida 33511
United States

Michelle Fleshner, AA
Phone: 813-684-2211
Email: mfleshner@brandoneyeassociates.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.